Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Scopus BioPharma Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-20Dec-31-19
Revenues0.00.0
Cost of goods sold0.00.0
Gross profit0.00.0
Research and development7.40.5
General and administrative2.72.2
EBIT-10.2-2.7
Pre-tax income-10.9-2.7
Income taxes0.00.0
            Tax rate0.0%0.0%
Net income-10.9-2.7
 
Diluted EPS($0.81)($0.22)
Shares outstanding (diluted)13.412.0
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy